Guggenheim Initiates Coverage on SOPHiA GENETICS (NASDAQ:SOPH)
Stock analysts at Guggenheim began coverage on shares of SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) in a report issued on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $6.00 price target on the stock. Guggenheim’s price target indicates a potential upside of 31.00% from the company’s current price. A number of […]
More Stories
Walt Disney (NYSE:DIS) Price Target Raised to $130.00
Walt Disney (NYSE:DIS – Free Report) had its price target increased by Guggenheim from $110.00 to $130.00 in a report...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Short Interest Update
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) saw a significant growth in short interest during the month of October....
South Street Advisors LLC Trims Stock Position in RTX Co. (NYSE:RTX)
South Street Advisors LLC cut its stake in shares of RTX Co. (NYSE:RTX – Free Report) by 7.5% in the...
Kulicke and Soffa Industries (NASDAQ:KLIC) Raised to “Buy” at Needham & Company LLC
Needham & Company LLC upgraded shares of Kulicke and Soffa Industries (NASDAQ:KLIC – Free Report) from a hold rating to...
Maxwell Wealth Strategies Inc. Grows Position in Tesla, Inc. (NASDAQ:TSLA)
Maxwell Wealth Strategies Inc. lifted its position in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 580.1% in the...
9,068 Shares in Pfizer Inc. (NYSE:PFE) Bought by Turtle Creek Wealth Advisors LLC
Turtle Creek Wealth Advisors LLC bought a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the 3rd quarter,...